About half of all liver disease is alcohol related, a third is caused by viral hepatitis and the remainder due to immune system dysfunction, metabolic disorders and inherited diseases.
The firm plans to invest in three main areas: cancer, metabolic diseases like diabetes and obesity, and diseases of the central nervous system such as Alzheimer's, depression and schizophrenia.